Disc Medicine, Inc. (IRON)
60.95
-3.41
(-5.30%)
USD |
NASDAQ |
Mar 04, 16:00
60.95
0.00 (0.00%)
After-Hours: 18:39
Disc Medicine Research and Development Expense (Annual) : 170.36M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 13.34B |
| Boston Scientific Corp. | 2.052B |
| Penumbra, Inc. | 69.43M |
| Rapt Therapeutics, Inc. | 107.22M |
| Amylyx Pharmaceuticals, Inc. | 103.18M |